Geneos Therapeutics
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
660 W Germantown Pike Ll 100, Plymouth M...Phone Number
(267) 440-4232Website
www.geneostx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Geneos Therapeutics
Geneos Therapeutics is a clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer. Established in 2016, Geneos Therapeutics is headquartered in Pennsylvania, United States.Explore more
Geneos Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Geneos Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Geneos Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Geneos Therapeutics has new funding data
Check out if Geneos Therapeutics is spiking on competitors!
Geneos Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Geneos Therapeutics had a recent Job posting/layoffs
Check if Geneos Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Geneos Therapeutics
Product Launch: Get notified when Geneos Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Geneos Therapeutics
Compare insights from companies similar to Geneos Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Geneos Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Geneos Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Geneos Therapeutics.
Geneos Therapeutics financials insights
Gather financial insights about Geneos Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2023
Series A
$45.5M
Geneos Therapeutics Tech Stack
A closer look at the technologies used by Geneos Therapeutics
See more technologies
Most Recent Scoops
Event
Events, Engineering, Sales, Learning & Development, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, HR Operations, Operations, Patient Experience
Funding
Funding
New Hire
Executive Move
Promotion
Executive Move
Geneos Therapeutics News & Media
Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
PHILADELPHIA, March 6, 2024 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced the upcoming presentation of two posters sharing new clinical data from its Phase 1b/2a...Philly Money Moves: University City Science Center got a big NIH grant
Also, Geneos Therapeutics raised $10 million, Center for Breakthrough Therapeutics was acquired, Moore College of Art and Design received a grant for a VR exhibit, and more local funding news.Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million
-- Proceeds Will Fund Completion of GT-30 Trial of Personalized Therapeutic Cancer Vaccine in Liver Cancer -- -- Shanghai-based SHC Added to Geneos' Investor Syndicate -- PLYMOUTH MEETING, Pa., Sept. 27, 2023 /PRNewswire/ -- Geneos Therapeutics, a clinical stage biotherapeutics company...Geneos Therapeutics Announces Eight of 34 Patients to Achieve Complete Response, Complete Molecular Response, or, Secondary Resectability in Ongoing Clinical Trial of Personalized Therapeutic Cancer Vaccination in Second Line Advanced Liver Cancer
--By RECIST1.1, Three Complete Responses and Seven Durable Partial Responses Achieved to Date-- --Three of the Seven Patients With Durable Partial Responses, and One With Stable Disease, Have Now Achieved Complete Molecular Response By Ultrasensitive ctDNA Analysis-- --No Serious Adverse...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Geneos Therapeutics
Sign Up For FreeTo access detailed company insights
Geneos Therapeutics is a clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer. Established in 2016, Geneos Therapeutics is headquartered in Pennsylvania, United States.... Read More
